Each register and historical list with its number of registrations and a few of them.
Anvisa · 1 registration
Health Canada · 1 registration
AEMPS · 1 registration
EMA · 1 registration
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 1 registration
HSA · 1 registration
FDA · 1 registration
Human medicines from every register that match Donanemab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Kisunla | United States | 350MG/20ML | injectable | Marketed | Eli Lilly Co |
| Kisunla | European Union | Authorised | Eli Lilly Nederland B.V. | ||
| Kisunla 350 MG Concentrado Para Solucion Para Perfusion | Spain | 350 mg | concentrado para solución para perfusión | Marketed | Eli Lilly Nederland B.V. |
| Kisunla 350 mg concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Eli Lilly Nederland B.V. | |
| Kisunla | Canada | 17.5 MG / ML | Solution | Marketed | Eli Lilly Canada INC |
| Kisunla | Brazil | Authorised | Eli Lilly do Brasil Ltda | ||
| Lormalzi Concentrate for Solution for Infusion 350mg/20mL | Singapore | 350mg/20mL | infusion, solution concentrate | Authorised | DKSH Singapore Pte. LTD. |
| Kisunla | Croatia | Authorised |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada and HSA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
